Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

Evolent Health, Inc Class A Common Stock (NY:EVH)

3.380 -0.110 (-3.15%)
Streaming Delayed Price Updated: 10:19 AM EDT, Oct 1, 2026 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

All News about Evolent Health, Inc Class A Common Stock

< Previous 1 2 3 4 5 6 7 8 9 10 Next >
News headline image
Healthcare Technology for Providers Stocks Q2 In Review: Astrana Health (NASDAQ:ASTH) Vs Peers
Wrapping up Q2 earnings, we look at the numbers and key takeaways for the healthcare technology for providers stocks, including Astrana Health (NASDAQ:ASTH) ... 
Via StockStory
News headline image
Q2 Earnings Highlights: Tandem Diabetes (NASDAQ:TNDM) Vs The Rest Of The Healthcare Technology Stocks
Quarterly earnings results are a good time to check in on a company’s progress, especially compared to its peers in the same sector. Today we are looking at ... 
Via StockStory
News headline image
3 Reasons to Avoid EVH and 1 Stock to Buy Instead
The past six months have been a windfall for Evolent Health’s shareholders. The company’s stock price has jumped 48.6%, hitting $3.70 per share. This was par... 
Via StockStory
Topics Bankruptcy
News headline image
Q2 Healthcare Technology for Providers Earnings: Evolent Health (NYSE:EVH) Impresses
Looking back on healthcare technology for providers stocks’ Q2 earnings, we examine this quarter’s best and worst performers, including Evolent Health (NYSE:... 
Via StockStory
Evolent Health (NYSE:EVH) Jumps 18% After Q2 Revenue and EPS Smash Estimates ↗
Via Chartmill
Evolent Health Inc - A (NYSE:EVH) Q1 Revenue Miss Overshadowed by EPS Beat ↗
Via Chartmill
News headline image
1 of Wall Street’s Favorite Stocks for Long-Term Investors and 2 We Find Risky
Wall Street has set ambitious price targets for the stocks in this article. While this suggests attractive upside potential, it’s important to remain skeptic... 
Via StockStory
News headline image
Healthcare Technology for Providers Stocks Q2 Teardown: Privia Health (NASDAQ:PRVA) Vs The Rest
Looking back on healthcare technology for providers stocks’ Q2 earnings, we examine this quarter’s best and worst performers, including Privia Health (NASDAQ... 
Via StockStory
News headline image
1 Value Stock with Promising Prospects and 2 That Underwhelm
Value stocks typically trade at discounts to the broader market, offering patient investors the opportunity to buy businesses when they’re out of favor. The ... 
Via StockStory
News headline image
Evolent Health (EVH) Q2 2026 Earnings Call Transcript ↗
Highmark launch drove 47% revenue growth; AI platform reached meaningful scale. 
Via The Motley Fool
Topics Artificial Intelligence Earnings
News headline image
5 Must-Read Analyst Questions From Evolent Health’s Q2 Earnings Call
Evolent Health’s second quarter results drew a significant positive market reaction, reflecting outperformance versus Wall Street’s expectations on both reve... 
Via StockStory
Topics Earnings
News headline image
1 Healthcare Stock Worth Your Attention and 2 We Brush Off
Healthcare companies are pushing the status quo by innovating in areas like drug development and digital health. Shareholders who bet on the industry have be... 
Via StockStory
News headline image
Reflecting On Healthcare Technology Stocks’ Q2 Earnings: GoodRx (NASDAQ:GDRX)
Earnings results often indicate what direction a company will take in the months ahead. With Q2 behind us, let’s have a look at GoodRx (NASDAQ:GDRX) and its ... 
Via StockStory
News headline image
3 Stocks Under $10 with Questionable Fundamentals
Stocks trading in the $1-10 range are generally smaller players with less risk than their penny stock counterparts. But that doesn’t mean the underlying busi... 
Via StockStory
Topics Artificial Intelligence
News headline image
Evolent Health Q2 Earnings Call Highlights ↗
Evolent Health (NYSE:EVH) reported second-quarter revenue of $653 million, up 31% from the first quarter, and adjusted EBITDA of $28 million, up 27% sequentially, as the company benefited from the May... 
Via MarketBeat
Topics Earnings
News headline image
EVH Q2 2026 Deep Dive: Oncology Suite and AI Automation Drive Growth Amid Membership Headwinds
Healthcare solutions company Evolent Health (NYSE:EVH) reported Q2 CY2026 results beating Wall Street’s revenue expectations, with sales up 46.9% year on yea... 
Via StockStory
Topics Artificial Intelligence
News headline image
Evolent Health (NYSE:EVH) Reports Bullish Q2 CY2026, Stock Jumps 18.2%
Healthcare solutions company Evolent Health (NYSE:EVH) reported Q2 CY2026 results beating Wall Street’s revenue expectations, with sales up 46.9% year on yea... 
Via StockStory
News headline image
Evolent Health Earnings: What To Look For From EVH
Healthcare solutions company Evolent Health (NYSE:EVH) will be reporting earnings this Thursday before market hours. Here’s what to look for. Evolent Health ... 
Via StockStory
News headline image
1 Small-Cap Stock for Long-Term Investors and 2 We Brush Off
Many small-cap stocks have limited Wall Street coverage, giving savvy investors the chance to act before everyone else catches on. But the flip side is that ... 
Via StockStory
News headline image
Why Evolent Health (EVH) Stock Is Nosediving
What Happened? Shares of healthcare solutions company Evolent Health (NYSE:EVH) fell 13% in the afternoon session after Wall Street firm Citi downgraded the ... 
Via StockStory
Topics Artificial Intelligence
News headline image
3 Unprofitable Stocks with Questionable Fundamentals
Unprofitable companies can burn through cash quickly, leaving investors exposed if they fail to turn things around. Without a clear path to profitability, th... 
Via StockStory
News headline image
Q1 Earnings Outperformers: Evolent Health (NYSE:EVH) And The Rest Of The Healthcare Technology for Providers Stocks
The end of the earnings season is always a good time to take a step back and see who shined (and who didn’t). Let’s take a look at how healthcare technology ... 
Via StockStory
Topics Artificial Intelligence
News headline image
Is Privia Health Stock a Buy After Hedge Fund Rubicon Founders Added Over 175,000 Shares to Its Position? ↗
Privia Health Group delivers technology-driven solutions to optimize physician practices and support value-based care nationwide. 
Via The Motley Fool
Topics Regulatory Compliance
News headline image
3 Healthcare Stocks We Approach with Caution
Healthcare companies are pushing the status quo by innovating in areas like drug development and digital health. Despite the rosy long-term prospects, short-... 
Via StockStory
News headline image
3 Reasons EVH is Risky and 1 Stock to Buy Instead
Over the last six months, Evolent Health’s shares have sunk to $3.96, producing a disappointing 5.7% loss - a stark contrast to the S&P 500’s 9.1% gain. This... 
Via StockStory
Topics Bankruptcy Stocks
News headline image
3 Russell 2000 Stocks We’re Skeptical Of
The Russell 2000 (^RUT) is home to many small-cap stocks, offering investors the chance to uncover hidden gems before the broader market catches on. However,... 
Via StockStory
News headline image
Evolent Health Q1 Earnings Call Highlights ↗
Evolent Health (NYSE:EVH) reported first-quarter 2026 results that management said were in line with expectations, while reiterating its full-year outlook and highlighting new contract wins, early... 
Via MarketBeat
Topics Earnings
News headline image
Evolent (EVH) Q1 2026 Earnings Call Transcript ↗
Evolent (EVH) Q1 2026 Earnings Call Transcript 
Via The Motley Fool
Topics Artificial Intelligence Earnings
News headline image
Why Is Evolent Health (EVH) Stock Soaring Today
What Happened? Shares of healthcare solutions company Evolent Health (NYSE:EVH) jumped 15.8% in the afternoon session after the company reported decent first... 
Via StockStory
Topics Earnings
News headline image
Evolent Health (NYSE:EVH) Misses Q1 CY2026 Revenue Estimates, But Stock Soars 5.1%
Healthcare solutions company Evolent Health (NYSE:EVH) missed Wall Street’s revenue expectations in Q1 CY2026 as sales rose 2.6% year on year to $496.2 milli... 
Via StockStory
Topics Artificial Intelligence
< Previous 1 2 3 4 5 6 7 8 9 10 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.